Investor: Betting on Bio in 2026 Is Like Betting on Robotics in 2023

Earthling VC's Arian Ghashghai closed his 7th bio deal of 2026, arguing that betting on biotech now mirrors betting on robotics in 2023, driven by AI cost reductions and an influx of talent.

2026-10-07 ~ 2026-10-07 · 2 related posts

• Investor: Betting on Bio in 2026 Looks Like Robotics in 2023 — Cheap, Undervalued, Talent Influx — arian_ghashghai · 2026-10-07
• Earthling VC doubles down on bio with 7th deal of 2026, likening it to robotics in 2023 — arian_ghashghai · 2026-10-07